申请人:Merck Sharp & Dohme Ltd.
公开号:US06518273B1
公开(公告)日:2003-02-11
The present invention relates to compounds of the formula (I):
wherein R1a, R1b, R2, R3, R4, R5, X and n are defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia.
本发明涉及以下式(I)的化合物:其中R1a、R1b、R2、R3、R4、R5、X和n在此有所定义。这些化合物特别适用于治疗或预防抑郁症、焦虑、疼痛、炎症、偏头痛、呕吐和带状疱疹后神经痛。